Product NDC: | 65841-673 |
Proprietary Name: | Venlafaxine Hydrochloride |
Non Proprietary Name: | Venlafaxine Hydrochloride |
Active Ingredient(s): | 50 mg/1 & nbsp; Venlafaxine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-673 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077653 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080613 |
Package NDC: | 65841-673-16 |
Package Description: | 90 TABLET in 1 BOTTLE (65841-673-16) |
NDC Code | 65841-673-16 |
Proprietary Name | Venlafaxine Hydrochloride |
Package Description | 90 TABLET in 1 BOTTLE (65841-673-16) |
Product NDC | 65841-673 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Venlafaxine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080613 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |